Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 0355220090340040429
Journal of Korean Academy Oral Medicine
2009 Volume.34 No. 4 p.429 ~ p.433
Topical Application of Clonazepam to Burning Mouth Syndrome
Shim Young-Joo

Choe Jong-Hun
Ahn Hyung-Joon
Kwon Jeong-Seung
Abstract
Burning mouth syndrome (BMS) is defined as burning pain in the tongue or other oral mucous membrane associated with normal sign and laboratory findings at least 4 to 6 months. There are many factors that affect this condition and the pain characters are various among the sufferers, so it is difficult to diagnose exactly and treat properly.
The cause of BMS is currently unknown. The etiology is presumed to be that it is related with local, systemic and psychogenic factor. The BMS is related with local factor such as allergic reaction, oral fungal infection(candidiasis), parafunctional oral habits and systemic factors such as diabetes mellitus, hypothyroidism, nutritional deficiencies(vitamin B12, folic acid), hyposalivation and psychogenic factor such as depression, anxiety, cancerphobia. So clinicians must be aware of these factors and can give proper treatment options to patients.
The management of BMS are pharmacologic management, cognitive behavioral therapy and psychotherapy treatment. Clonazepam, gabapentin, amitriptyline, alpha-lipoic acid and capsaicin are used to manage the BMS. Among these, topical clonazepam is reported that the effect is higher than systemic medication and the complications are rare.
This case report is about some cases of the effect of topical clonazepam on BMS.
KEYWORD
Burning mouth syndrome, Clonazepam, Neuroactive steroid
FullTexts / Linksout information
  
Listed journal information
ÇмúÁøÈïÀç´Ü(KCI)